Patient-Reported Outcomes (PROs) and Safety in Patients (Pts) With NDMM Achieving MRD Negativity and ≥CR (MRDneg) in the Phase 3 PERSEUS and CEPHEUS Trials — Jesús F. San Miguel (2025) | RDL Network
Patient-Reported Outcomes (PROs) and Safety in Patients (Pts) With NDMM Achieving MRD Negativity and ≥CR (MRDneg) in the Phase 3 PERSEUS and CEPHEUS Trials
Marcelo Pitombeira de Lacerda, Meletios A Dimopoulos, Luděk Pour, Kihyun Kim, Sergey Voloshin, Hanlon Sia, Esther González, Chang‐Ki Min, Anna Sureda, Ivan Spicka, Paweł Robak, Marek Hus, Vera Zherebtsova, Merit Hanna, Vinay Jadhav, Nicholas Pirooz, Ianire Garrobo-Calleja, Lydia Eccersley, Vânia Hungria, Meral Beksaç
Alessandra Tedeschi, Meletios A Dimopoulos, Judith Trotman, Ramón García‐Sánz, D. Blair Macdonald, Beatrice Mahé, Charles Herbaux, Leonard T. Heffner, Constantine S. Tam, Marzia Varettoni, M. Lia Palomba, J. Matous, Chaim Shustik, Efstathios Kastritis, Steven P. Treon, J. Li, Erik Poulsen, B. Hauns, Christian Buske, V. Leblond
William D. Tap, Vivek A. Bhadri, Silvia Stacchiotti, Sebastian Bauer, Andrew J. Wagner, Michiel A. J. van de Sande, Nicholas M. Bernthal, Antonio López–Pousa, Albiruni Ryan Abdul Razak, Antoîne Italiano, Mahbubl Ahmed, Axel Le Cesne, Christopher Tait, Fiona Zarins, B. Harrow, Maitreyi G. Sharma, Rodrigo Ruiz‐Soto, Matthew L. Sherman, Jean Yves Blay, Hans Gelderblom
Alessandra Tedeschi, Meletios A Dimopoulos, Judith Trotman, Ramón García‐Sánz, David MacDonald, Beatrice Mahé, Charles Herbaux, Leonard T. Heffner, Constantine S. Tam, Marzia Varettoni, Maria Lia Palomba, Jeffrey Matous, Chaim Shustik, Efstathios Kastritis, Steven P. Treon, Jianling Li, Erik Poulsen, Bernhard Hauns, Christian Buske, Véronique Leblond
Discussion(0)
No comments yet. Be the first to comment.